Document Detail


Lyso platelet activating factor (LysoPAF) and its enantiomer. Total synthesis and carbon-13 NMR spectroscopy.
MedLine Citation:
PMID:  2079867     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Described is a reaction sequence for the total synthesis of lyso platelet activating factor (lysoPAF; 1-O-alkyl-sn-glycero-3-phosphocholine) and its enantiomer. The procedure is versatile and yields optically pure isomers of defined chain length. The synthesis is equally suited for the preparation of lysoPAF analogues and its enantiomers with unsaturation in the long aliphatic chain. First, rac-1(3)-O-alkylglycerol is prepared by alkylation of rac-isopropylideneglycerol with alkyl methanesulfonate followed by acid-catalyzed removal of the ketal group. The primary hydroxy group of alkylglycerol is then protected by tritylation, the secondary hydroxy group is acylated, and the protective trityl group is removed under mild acidic conditions with boric acid on silicic acid, essentially without acyl migration. Condensation of the diradylglycerol with bromoethyl dichlorophosphate in diethyl ether, hydrolysis of the resulting chloride, and nucleophilic displacement of the bromine with trimethylamine gives rac-1-O-alkyl-2-acylglycero-3-phosphocholine in good overall yield. The racemic alkylacylglycerophosphocholine is finally treated with snake venom phospholipase A2 (Ophiophagus hannah) which affords 1-O-alkyl-sn-glycero-3-phosphocholine (lysoPAF) of natural configuration in optically pure form. The "unnatural" 3-O-alkyl-2-O-acyl-sn-glycero-1-phosphocholine enantiomer, which is not susceptible to phospholipase A2 cleavage, gives 3-O-alkyl-sn-glycero-1-phosphocholine upon deacylation with methanolic sodium hydroxide. Homogeneity and structure of the intermediates and final products were ascertained by carbon-13 nuclear magnetic resonance spectroscopy on monomeric solutions.
Authors:
M P Murari; R Murari; S Parthasarathy; C A Guy; V V Kumar; B Malewicz; W J Baumann
Related Documents :
17878977 - The enantioselective synthesis of apto and aetd: polyhydroxylated beta-amino acid const...
17549687 - Catalytic activation through metal enolization of nucleophile precursors and synthetic ...
19072097 - Annulations of enantioenriched allenylsilanes with in situ generated iminium ions: ster...
12868907 - Novel one-pot vicinal double c-acylation of styrenes and methacrylates by electroreduct...
6513607 - Ageing and compositional changes of rat lens.
527937 - Nicotinic acid metabolism. 2,3-dimethylmalate lyase.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Lipids     Volume:  25     ISSN:  0024-4201     ISO Abbreviation:  Lipids     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1991-04-26     Completed Date:  1991-04-26     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0060450     Medline TA:  Lipids     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  606-12     Citation Subset:  IM    
Affiliation:
Section of Bio-Organic Chemistry, Hormel Institute, University of Minnesota, Austin 55912.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acylation
Alkylation
Chemical Phenomena
Chemistry
Magnetic Resonance Spectroscopy
Molecular Structure
Platelet Activating Factor / analogs & derivatives*,  chemical synthesis,  chemistry
Stereoisomerism
Grant Support
ID/Acronym/Agency:
HL07311/HL/NHLBI NIH HHS; HL08214/HL/NHLBI NIH HHS; RR 04654/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/O-deacetyl platelet activating factor; 0/Platelet Activating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accumulation of eicosapentaenoic acid in plasma phospholipids of subjects fed canola oil.
Next Document:  Composition of mouse peritoneal macrophage phospholipid molecular species.